SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-192490
Filing Date
2014-05-09
Accepted
2014-05-09 16:17:52
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d703004d10q.htm 10-Q 240394
2 CERTIFICATION d703004dex311.htm EX-31.1 6036
3 CERTIFICATION d703004dex312.htm EX-31.2 6015
4 CERTIFICATION d703004dex321.htm EX-32.1 2654
5 CERTIFICATION d703004dex322.htm EX-32.2 2633
  Complete submission text file 0001193125-14-192490.txt   2181519

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20140331.xml EX-101.INS 222986
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20140331.xsd EX-101.SCH 32644
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20140331_cal.xml EX-101.CAL 32245
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20140331_def.xml EX-101.DEF 68588
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20140331_lab.xml EX-101.LAB 225058
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20140331_pre.xml EX-101.PRE 139896
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 14829338
SIC: 2834 Pharmaceutical Preparations